Expired Tender India NCB TOT Ref. 150879970

Rate for Ranibizumab 10 Mg/Ml Injection Tender - 150879970

Tender notice from India, published on 13 Oct 2026.

Executive Summary

The NORTH CENTRAL RAILWAY has issued a Tender notice for the procurement of a Rate for Ranibizumab 10 Mg/Ml Injection & Bevacizumab 25Mg/Ml Injection (Only Railway Registered Manufacturing Firms Product will be Accepted ) in the India.The project location is Prayagraj, Uttar Pradesh, India. This Tender notice was published on 13 Oct 2026 and is scheduled to close on 16 Oct 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 150879970, while the tender notice number is BLP26-27-48R and Register on the platform.

Key facts

Summary
Rate for Ranibizumab 10 Mg/Ml Injection & Bevacizumab 25Mg/Ml Injection (Only Railway Registered Manufacturing Firms Product will be Accepted )
TOT Ref. No.
150879970
Document Ref. No.
BLP26-27-48R
State
Uttar Pradesh
Notice type
Tender
Competition
NCB
Publication date
13 Oct 2026
Bid deadline
16 Oct 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Procurement Type
Goods
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Ranibizumab 10 Mg/Ml Injection.(Item No.2558, Ami-2026-27) ]

Contract Category: Expenditure
Contract Type : Goods

Tender Type : Limited - Indigenous

Contract Category : Expenditure

Evaluation Criteria : Itemwise/Consigneewise

Bidding System : Single Packet

Pre-Bid Conference Required : No

Pre-Bid Conference Date Time : Not Applicable

Tendering Section : MEDICAL

Inspection Agency : CONSIGNEE

Publishing Date / Time : 13/10/2026 16:17 Item Category General

Procure From Approved Sources : No

Approving Agency : Not Applicable

Closing Date Time : 16/10/2026 12:00

Validity of Offer ( Days) : 120

Ranking Order for Bids : Lowest to Highest

Advertised Value :

Tender Doc. Cost (INR) : 0.00

Earnest Money (INR) : 0.00 MSE Preference Parameters MSE Reserved Item No Purchase Preference Quantity (%) 25 Margin of Preference (%) 15 Make In India (MII) Parameters MII policy is not applicable for cases with Estimated Value is less than 5 Lacs
Consignee 011265 : CMS/CNB Uttar Pradesh 10.00 Numbers

2 2 Goods (Y) Non Stock --- Yes CONSIGNEE INR

Description : BEVACIZUMAB 25MG/ML INJECTION(ITEM NO.2532, AMI-2026-27) ]

Consignee 011265 : CMS/CNB Uttar Pradesh 1.00 Numbers

Documents

Tender Notice
Login to view
viewNitPdf_5568658.pdf
Login to view
TERMSCONDITIONSBLP.pdf
Login to view

India Public Procurement Intelligence

Frequently asked questions

The bid deadline for Rate for Ranibizumab 10 Mg/Ml Injection & Bevacizumab 25Mg/Ml Injection (Only Railway Registered Manufacturing Firms Product will be Accepted ) was 16 Oct 2026. Bidding is closed.

This tender has been issued by NORTH CENTRAL RAILWAY in India.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

This is a Goods procurement tender issued as a public sector opportunity in India.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 150879970. The purchaser document reference is BLP26-27-48R.

Browse other tenders from India or search by relevant keywords and CPV classification.